GlaxoSmithKline
GSK
#155
Rank
$98.16 B
Marketcap
🇬🇧 UK
Country
$39.02
Share price
-1.24%
Change (1 day)
-4.99%
Change (1 year)
Earnings for GlaxoSmithKline (GSK)
Earnings in 2021 (TTM): $10.66 B
According to GlaxoSmithKline's latest financial reports the company's current earnings (TTM) are $10.66 B. In 2020 the company made an earning of $11.15 B an increase over its 2019 earnings that were of $10.07 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for GlaxoSmithKline from 2001 to 2021
| Year | Earnings | Change |
|---|---|---|
| 2021 (TTM) | $10.66 B | -4.39% |
| 2020 | $11.15 B | 10.65% |
| 2019 | $10.07 B | 27.55% |
| 2018 | $7.90 B | 30.74% |
| 2017 | $6.04 B | 60.43% |
| 2016 | $3.76 B | -76.41% |
| 2015 | $15.97 B | 206.76% |
| 2014 | $5.20 B | -50.3% |
| 2013 | $10.47 B | -0.87% |
| 2012 | $10.56 B | -12.3% |
| 2011 | $12.05 B | 113.06% |
| 2010 | $5.65 B | -54.02% |
| 2009 | $12.30 B | 15.65% |
| 2008 | $10.63 B | 19.93% |
| 2007 | $8.86 B | -19.07% |
| 2006 | $10.95 B | 3040.65% |
| 2005 | $0.34 B | -95.99% |
| 2004 | $8.69 B | -3.96% |
| 2003 | $9.05 B | 11.75% |
| 2002 | $8.10 B | -6.41% |
| 2001 | $8.65 B |